Showing results (11-20 of 100) with videos related to
Sort By:
Pageof 10
Current Topics in Medicinal Chemistry|September 27, 2013
Vaccine adjuvants: key tools for innovative vaccine designPeggy Riese, Kai Schulze, Thomas Ebensen, et al.Pharmaceutics|April 27, 2024
Influenza Virus Inactivated by Heavy Ion Beam Irradiation Stimulates Antigen-Specific Immune ResponsesKai Schulze, Ulrich Weber, Christoph Schuy, et al.Clinical and Vaccine Immunology : CVI|June 15, 2007
The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvantThomas Ebensen, Kai Schulze, Peggy Riese, et al.Vaccines|November 27, 2021
Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?Reiner Buchhorn, Carlotta Meyer, Kai Schulze-Forster, et al.Journal of Agricultural and Food Chemistry|April 14, 2005
Development of a radioimmunoassay for the quantitative determination of 8-prenylnaringenin in biological matricesOlaf Schaefer, Rolf Bohlmann, Wolf-Dieter Schleuning, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|June 6, 2017
Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in miceKai Schulze, Thomas Ebensen, Lorne A Babiuk, et al.Pharmaceutics|December 23, 2022
IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte ActivationAhmed E I Hamouda, Kai Schulze, Thomas Ebensen, et al.Molecular Therapy. Nucleic Acids|August 26, 2019
Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA VaccineFederico Perche, Rudy Clemençon, Kai Schulze, et al.Vaccine|December 26, 2006
The bacterial second messenger cyclic diGMP exhibits potent adjuvant propertiesThomas Ebensen, Kai Schulze, Peggy Riese, et al.Vaccine|May 31, 2011
Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvantThomas Ebensen, Rimma Libanova, Kai Schulze, et al.Pageof 10